74 results
Page 2 of 4
8-K
EX-99.1
buh0255nb8ibh 4a
11 Aug 20
Larimar Therapeutics Reports Second Quarter 2020 Operating and Financial Results
7:38am
8-K
EX-99.2
01i e3y8k
11 Aug 20
Larimar Therapeutics Reports Second Quarter 2020 Operating and Financial Results
7:38am
8-K
EX-99.1
2hvt5
6 Aug 20
Departure of Directors or Certain Officers
9:00am
8-K/A
EX-99.2
4kvkyb
26 Jun 20
Other Events
5:08pm
8-K
EX-99.1
fbpqnj
3 Jun 20
Regulation FD Disclosure
12:00am
8-K
0ev 0jfm0
2 Jun 20
Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics
7:49am
8-K
EX-14.1
du2n 5lcdjm3rs5fv
2 Jun 20
Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics
7:49am
8-K
EX-10.1
uvj4v7kc4t09xy5d gk
2 Jun 20
Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics
7:49am
8-K
EX-99.1
k0fbbsb0f4gjjr8i
2 Jun 20
Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics
7:49am
DEFM14A
pg4mj zkqht
29 Apr 20
Proxy related to merger
3:20pm
PRER14A
26jfpv stae
10 Apr 20
Preliminary revised proxy
4:38pm
PREM14A
aylc8l
6 Mar 20
Preliminary proxy related to merger
5:32pm
8-K
EX-2.1
husufus3yb1z18hi90zt
18 Dec 19
Zafgen and Chondrial Therapeutics Announce Definitive Merger Agreement
8:13am
DEFA14A
EX-2.1
gkhj9onk kj
18 Dec 19
Additional proxy soliciting materials
8:11am